Watch HCAT. Know when insiders buy.
One email the day a filing lands. Free.
HCAT
Health Catalyst, Inc.
1.73
+0.01 +0.58%
USD · Sep 17, 08:21 a.m. ET
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
77
PASS · insiders 60, shorts 93
Insiders, 90 days
+$105K
net buying · 1 buy, 0 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $130.2MP/E —DIV YIELD —FCF YIELD 20.76%REV TTM $292.2M −7.5%NET INCOME −$264.8MNET DEBT $92.9M52W 1.00 – 3.46SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $70.5M | −12.7% | — | −$36.5M | −$40.5M | — | -0.55 | $275K | $345K | −$70K | Aug 6 |
| Q1 2026 · Mar 31 | $70.8M | −10.9% | — | −$106.5M | −$111M | — | -1.53 | $18.5M | $338K | $18.2M | May 11 |
| Q4 2025 · Dec 31derived | $74.7M | −6.2% | — | −$86.1M | −$91M | — | -1.30 | $9.9M | $273K | $9.6M | Mar 12 |
| Q3 2025 · Sep 30 | $76.3M | −0.0% | 52.6% | −$17.5M | −$22.2M | — | -0.32 | −$464K | $255K | −$719K | Nov 10 |
| Q2 2025 · Jun 30 | $80.7M | +6.3% | — | −$37.1M | −$41M | — | -0.59 | −$9M | −$230K | −$8.8M | Aug 6 |
| Q1 2025 · Mar 31 | $79.4M | +6.3% | — | −$20.2M | −$23.7M | — | -0.35 | $280K | $670K | −$390K | May 11 |
| Q4 2024 · Dec 31derived | $79.6M | +6.0% | — | −$17.5M | −$20.7M | — | -0.33 | −$3.5M | $413K | −$3.9M | Mar 12 |
| Q3 2024 · Sep 30 | $76.4M | +3.5% | 47.5% | −$13.7M | −$14.7M | — | -0.24 | $6.2M | $705K | $5.5M | Nov 10 |
| Q2 2024 · Jun 30 | $75.9M | — | — | −$15.8M | −$13.5M | — | -0.23 | $1.6M | $290K | $1.3M | Aug 8 |
| Q1 2024 · Mar 31 | $74.7M | — | — | −$22.8M | −$20.6M | — | -0.35 | $10.3M | $208K | $10.1M | May 9 |
| Q4 2023 · Dec 31derived | $75.1M | — | — | −$32.8M | −$30.3M | — | -0.52 | −$19M | $255K | −$19.3M | Mar 12 |
| Q3 2023 · Sep 30 | $73.8M | — | — | −$24.6M | −$22M | — | -0.39 | $3.1M | $149K | $3M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $311.1M | — | −$160.9M | −$178M | -57.2% | -2.55 | $731K | $968K | −$237K | $5M | — |
| FY2024 · to Dec 31 | $306.6M | — | −$69.8M | −$69.5M | -22.7% | -1.15 | $14.6M | $1.6M | $12.9M | $0 | — |
| FY2023 · to Dec 31 | $295.9M | — | −$126.9M | −$118.1M | -39.9% | -2.09 | −$33.1M | $1.2M | −$34.3M | $1.8M | — |
| FY2022 · to Dec 31 | $276.2M | — | −$140M | −$137.4M | -49.7% | -2.63 | −$35.3M | $2.2M | −$37.4M | $8.4M | — |
| FY2021 · to Dec 31 | $241.9M | — | −$143.7M | −$153.2M | -63.3% | -3.23 | −$23.1M | $10.4M | −$33.6M | $0 | — |
| FY2020 · to Dec 31 | $188.8M | — | −$96.1M | −$115M | -60.9% | -2.91 | −$26.1M | $7.8M | −$33.9M | $0 | — |
Every number comes from Health Catalyst, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.